ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of Melflufen and Dexamethasone in Relapsed and/or Relapsed-Refractory Multiple Myeloma Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01897714
Recruitment Status : Active, not recruiting
First Posted : July 12, 2013
Last Update Posted : March 21, 2018
Sponsor:
Information provided by (Responsible Party):
Oncopeptides AB

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : December 2017
  Estimated Study Completion Date : October 2019